Cancer nanomedicine: progress, challenges and opportunities

被引：4562

作者：

Shi, Jinjun ^{[1
,2
]}

Kantoff, Philip W. ^{[3
]}

Wooster, Richard ^{[4
]}

Farokhzad, Omid C. ^{[1
,2
,5
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Ctr Nanomed, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA

[4] Tarveda Therapeut, Watertown, MA 02472 USA

[5] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia

来源：

NATURE REVIEWS CANCER | 2017年 / 17卷 / 01期

基金：

美国国家卫生研究院; 新加坡国家研究基金会;

关键词：

TUMOR-ASSOCIATED MACROPHAGES; CELL LUNG-CANCER; INCORPORATING MICELLAR NANOPARTICLE; PEGYLATED LIPOSOMAL DOXORUBICIN; SYSTEMICALLY ADMINISTERED SIRNA; POLYMER HYBRID NANOPARTICLES; PATIENT-DERIVED XENOGRAFTS; PHASE-III TRIAL; DRUG-DELIVERY; BREAST-CANCER;

D O I：

10.1038/nrc.2016.108

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The intrinsic limits of conventional cancer therapies prompted the development and application of various nanotechnologies for more effective and safer cancer treatment, herein referred to as cancer nanomedicine. Considerable technological success has been achieved in this field, but the main obstacles to nanomedicine becoming a new paradigm in cancer therapy stem from the complexities and heterogeneity of tumour biology, an incomplete understanding of nano bio interactions and the challenges regarding chemistry, manufacturing and controls required for clinical translation and commercialization. This Review highlights the progress, challenges and opportunities in cancer nanomedicine and discusses novel engineering approaches that capitalize on our growing understanding of tumour biology and nano bio interactions to develop more effective nanotherapeutics for cancer patients.

引用

页码：20 / 37

页数：18

共 249 条

[1] A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer [J].

Ahn, Hee Kyung ;

Jung, Minkyu ;

Sym, Sun Jin ;

Shin, Dong Bok ;

Kang, Shin Myung ;

Kyung, Sun Young ;

Park, Jeong-Woong ;

Jeong, Sung Hwan ;

Cho, Eun Kyung .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) :277-282

[2] Tumour-on-a-chip provides an optical window into nanoparticle tissue transport [J].

Albanese, Alexandre ;

Lam, Alan K. ;

Sykes, Edward A. ;

Rocheleau, Jonathan V. ;

Chan, Warren C. W. .

NATURE COMMUNICATIONS, 2013, 4

[3] Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].

Alexis, Frank ;

Pridgen, Eric ;

Molnar, Linda K. ;

Farokhzad, Omid C. .

MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515

[4] Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas [J].

Alizadeh, Darya ;

Zhang, Leying ;

Hwang, Jungyeon ;

Schluep, Thomas ;

Badie, Behnam .

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (02) :382-390

[5] Elasticity of Nanopartides Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting [J].

Anselmo, Aaron C. ;

Zhang, Mengwen ;

Kumar, Sunny ;

Vogus, Douglas R. ;

Menegatti, Stefano ;

Helgeson, Matthew E. ;

Mitragotri, Samir .

ACS NANO, 2015, 9 (03) :3169-3177

[6] High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin [J].

Arrieta, Oscar ;

Medina, Luis-Alberto ;

Estrada-Lobato, Enrique ;

Ramirez-Tirado, Laura-Alejandra ;

Mendoza-Garcia, Victor-Osvaldo ;

de la Garza-Salazar, Jaime .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) :211-215

[7] Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo [J].

Ashina, Kohei ;

Tsubosaka, Yoshiki ;

Nakamura, Tatsuro ;

Omori, Keisuke ;

Kobayashi, Koji ;

Hori, Masatoshi ;

Ozaki, Hiroshi ;

Murata, Takahisa .

PLOS ONE, 2015, 10 (07)

[8] Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo [J].

Ashton, Susan ;

Song, Young Ho ;

Nolan, Jim ;

Cadogan, Elaine ;

Murray, Jim ;

Odedra, Rajesh ;

Foster, John ;

Hall, Peter A. ;

Low, Susan ;

Taylor, Paula ;

Ellston, Rebecca ;

Polanska, Urszula M. ;

Wilson, Joanne ;

Howes, Colin ;

Smith, Aaron ;

Goodwin, Richard J. A. ;

Swales, John G. ;

Strittmatter, Nicole ;

Takats, Zoltan ;

Nilsson, Anna ;

Andren, Per ;

Trueman, Dawn ;

Walker, Mike ;

Reimer, Corinne L. ;

Troiano, Greg ;

Parsons, Donald ;

De Witt, David ;

Ashford, Marianne ;

Hrkach, Jeff ;

Zale, Stephen ;

Jewsbury, Philip J. ;

Barry, Simon T. .

SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (325)

[9] INTERCAPILLARY DISTANCE MEASUREMENT AS AN INDICATOR OF HYPOXIA IN CARCINOMA OF THE CERVIX UTERI [J].

AWWAD, HK ;

ELNAGGAR, M ;

MOCKTAR, N ;

BARSOUM, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1329-1333

[10] NEGATIVE STAINING OF PHOSPHOLIPIDS + THEIR STRUCTURAL MODIFICATION BY-SURFACE ACTIVE AGENTS AS OBSERVED IN ELECTRON MICROSCOPE [J].

BANGHAM, AD ;

HORNE, RW .

JOURNAL OF MOLECULAR BIOLOGY, 1964, 8 (05) :660-&

← 1 2 3 4 5 6 7 8 9 10 →